Drug-Disease-Based Network Pharmacology Practice Process
Author:
Su Weiwei,Li Panlin
Publisher
Springer Singapore
Reference11 articles.
1. Chen Y, Wu H, Nie YC, et al. Mucoactive effects of naringin in lipopolysaccharide-induced acute lung injury mice and beagle dogs. Environ Toxicol Pharmacol. 2014;38(1):279–87.
2. Liu Y, Wu H, Nie YC, et al. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-kappa B pathway. Int Immunopharmacol. 2011;11(10):1606–12.
3. Nie YC, Wu H, Li PB, et al. Anti-inflammatory effects of naringin in chronic pulmonary neutrophilic inflammation in cigarette smoke-exposed rats. J Med Food. 2012;15(10):894–900.
4. Liu MH, Zou W, Yang CP, et al. Metabolism and excretion studies of oral administered naringin, a putative antitussive, in rats and dogs. Biopharm Drug Dispos. 2012;33:123–34.
5. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57.